About Camus Pharma Private Limited
Data last updated:
Camus Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 July 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1997PTC013970. Its GSTIN is 08AAACC7536L1ZE (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹26 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Suresh Chandra Dhabash and Dinesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 29 B Suraj Nagar Eastcivil Lines Jaipur 302006, Rajasthan, India – 302006.
As per the financials filed for FY 2025, the company reported a revenue of ₹121.82 Cr, a growth of 68% compared to the previous year. For the same year it recorded a net profit of ₹3.98 Cr (net margin 3.3%) and EBITDA of ₹7.34 Cr (EBITDA margin 6%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 5% over five years.
Its group structure includes 4 subsidiaries.
The company is associated with 1 brand: Camus Pharma. As per MCA filings, the company has open charges of ₹1.5 Cr and satisfied charges of ₹18.52 Cr on record. Court records list 22 cases involving the company, including 15 filed by the company and 6 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website camuspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address29 B Suraj Nagar Eastcivil Lines Jaipur 302006, Rajasthan, India – 302006
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Camus Pharma Private Limited
The main business activity of Camus Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Camus Pharma Private Limited FY 2025 filings available
Camus Pharma Private Limited reported revenue of ₹121.82 Cr (up 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Camus Pharma Private Limited
Revenue rose 68% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 218% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Camus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.34 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.98 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Camus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Camus Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Camus Pharma Private Limited
Camus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Valsad, Gujarat, India |
| Nirchem Dyes & Chemicals Private Limited | ₹122.53 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Ihl Lifesciences Private Limited | ₹122.51 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Indore, Madhya Pradesh, India |
| Realcade Lifescience Private Limited | ₹122.35 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Kadi, Gujarat, India |
| Nuray Chemicals Private Limited | ₹122.27 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Thiruvallur, Tamil Nadu, India |
| Camus Pharma Private Limited this company | ₹121.82 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Jaipur, Rajasthan, India |
| Unimarck Healthcare Limited | ₹121.56 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Delhi, India |
| Aurochem Laboratories (India) Private Limited | ₹121.52 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Glenfin Chemicals Private Limited | ₹121.15 Cr (FY 2023) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
| Vivimed Labs Limited Listed | ₹120.64 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Karnataka, India |
| Glensmith Labs Private Limited | ₹120.6 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Camus Pharma by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Camus Pharma Private Limited
Camus Pharma Private Limited is audited by H. C. BOTHRA AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H. C. BOTHRA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Camus Pharma Private Limited
Camus Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Chandra Dhabash Also directs: Camus Builders Private Limited, Crad Biochem Private Limited | Director | 20 Sep 2018 | 8 Years 0 Months | Current |
| Dinesh Kumar | Director | 20 Sep 2018 | 8 Years 0 Months | Current |
Ownership and Shareholding of Camus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Camus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2024 | Others | ₹1.5 Cr | Satisfied |
| 19 Nov 2022 | Others | ₹7.85 Cr | Satisfied |
| 04 May 2018 | Others | ₹15 Lakh | Satisfied |
| 16 Mar 2018 | Others | ₹5 Lakh | Satisfied |
| 18 Dec 2017 | Others | ₹2.07 Cr | Satisfied |
Total charge records: 10 View all charges
Legal Cases of Camus Pharma Private Limited
Camus Pharma Private Limited has 22 court cases on record: 15 filed by Camus Pharma, 6 filed against it, 1 where it is another party. 6 cases are pending and 16 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 0 | 5 |
| District courts | 7 | 6 | 1 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against Servo-Med Industries Private Limited | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Servo-Med Industries Private Limited | Pending |
| Bombay High Court | Commercial suit | Filed by the company against Snowbell Machines Private Limited | Pending |
| District court, Thane, Maharashtra | Court case (Spl .Dkst) | Filed against the company by Servo-Med Industries Private Limited | Pending |
| Bombay High Court | Court case (MCA) | Filed by the company against Snowbell Machines Private Limited | Disposed |
Full case history
All 22 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Camus Pharma Private Limited
Camus Pharma Private Limited has 12 MSME Form 1 returns on record between 2011 and 2024, listing 34 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Arene Life Sciences Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Gansons Private Limited | •••• | •••• | •••• |
| Airtech Systems (India) Private Limited | •••• | •••• | •••• |
| Snowbell Machines Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 12 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Camus Pharma Private Limited
Camus Pharma operates one associated brand: Camus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical trading and manufacturing of high-value drugs for medical conditions in India. | camuspharma.com |
Employees and EPFO Compliance at Camus Pharma Private Limited
Employment history and EPFO contributions of people linked to Camus Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Camus Pharma Private Limited
Camus Pharma has 4 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Chemerix Life Sciences Private Limited | U24230RJ2022PTC083509 | Locked |
| Chemerix Biotech Private Limited | U24304RJ2017PTC058071 | Locked |
| Camus Builders Private Limited | U45201RJ2007PTC024794 | Locked |
| Sunrise Dreamestate Private Limited | U45201RJ2010PTC033094 | Locked |
Showing major subsidiaries. Total: 4.
Recent Activity on Camus Pharma Private Limited
Camus Pharma Private Limited has 11 board changes on record since 2017: 2 appointments and 9 cessations. The latest: Kaushalya Punia ceased to be Director on 01 Nov 2018.
24 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Camus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Camus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Camus Pharma Private Limited
Camus Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACC7536L1ZE | Rajasthan | Active | 01 Jul 2017 |
| 36AAACC7536L1ZF | Telangana | Active | 26 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Camus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Camus Pharma Private Limited
Camus Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 July 1997 (29+ years old) and is registered under CIN U24232RJ1997PTC013970.
Camus Pharma reported revenue of ₹121.82 Cr for FY 2025 (up 68% YoY).
Camus Pharma has 2 current directors:
- Suresh Chandra Dhabash - Director
- Dinesh Kumar - Director
Camus Pharma reported a net profit of ₹3.98 Cr (net margin 3.3%) and EBITDA of ₹7.34 Cr (EBITDA margin 6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Camus Pharma is 37% over three years and -5% over five years. In the latest year (FY 2025) revenue rose 68%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Camus Pharma is 08AAACC7536L1ZE, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAACC7536L1ZF (Telangana).
The CIN (Corporate Identification Number) of Camus Pharma is U24232RJ1997PTC013970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Camus Pharma has 22 court cases on record: 15 filed by the company and 6 filed against it. 6 are pending. Most are in the high courts.
Camus Pharma was incorporated on 01 July 1997, making it 29+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Camus Pharma by revenue are Richter Themis Medicare (India) Private Limited, Nirchem Dyes & Chemicals Private Limited, Ihl Lifesciences Private Limited, Realcade Lifescience Private Limited, Nuray Chemicals Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Formulations).
Kaushalya Punia ceased to be Director on 01 Nov 2018. Amod Kumar Mishra ceased to be Director on 01 Oct 2018. Dinesh Kumar ceased to be Additional Director on 30 Sep 2018. Camus Pharma has 11 board changes on record in total.
Camus Pharma has 12 MSME Form 1 returns on record between 2011 and 2024, listing 34 overdue payments to 6 micro and small suppliers. The latest return was filed on 01 May 2024.